Strategies for the Inhibition of Protein Aggregation in Human Diseases
- 10 May 2010
- journal article
- review article
- Published by Wiley in ChemBioChem
- Vol. 11 (8), 1018-1035
- https://doi.org/10.1002/cbic.200900666
Abstract
Protein misfolding and aggregation has been related to several human disorders, generally termed protein aggregation diseases. These diseases include neurodegenerative disorders such as Alzheimer's, Parkinson's, and Huntington's diseases and peripheral disorders such as systemic amyloidosis and type 2 diabetes. The complexity of the aggregation processes and the intertwined events account for the fact that no effective disease‐modifying treatments for these disorders are currently available. Nevertheless, in‐depth research into the aggregation processes has recently yielded major insights into some key mechanisms of aggregation‐mediated cell toxicity, offering new targets for drug development. In addition, recent findings in the field have identified similar features, revealing the possibility of shared mechanisms and hence potential common approaches for intervention. This review aims to give an overview of potential strategies for tackling protein aggregation and its associated toxicity, focusing on protein aggregation in human disease.Keywords
This publication has 101 references indexed in Scilit:
- Targeting HSP70 for Cancer TherapyMolecular Cell, 2009
- Design and biological activity of β-sheet breaker peptide conjugatesBiochemical and Biophysical Research Communications, 2009
- An in vitro screening cascade to identify neuroprotective antioxidants in ALSFree Radical Biology & Medicine, 2009
- Prion protein misfolding and diseaseCurrent Opinion in Structural Biology, 2009
- α-Synuclein: A therapeutic target for Parkinson’s disease?Pharmacological Research, 2008
- β-Secretase as a Therapeutic Target for Alzheimer's DiseaseNeurotherapeutics, 2008
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- An scFv Intrabody against the Nonamyloid Component of α-Synuclein Reduces Intracellular Aggregation and ToxicityJournal of Molecular Biology, 2007
- Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigmBiochimica et Biophysica Acta (BBA) - Biomembranes, 2007
- Isolation of a Human Single Chain Antibody Fragment Against Oligomeric α-Synuclein that Inhibits Aggregation and Prevents α-Synuclein-induced ToxicityJournal of Molecular Biology, 2007